This is a summary of the European public assessment report (EPAR) for Vimpat. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 month ago
Brussels (Belgium), Monday 30th June, 2014 - 0700 (CEST) - UCB today announced data from two studies evaluating the efficacy and safety of VIMPAT® (lacosamide) as early adjunctive treatment in adults with partial-onset seizures. The results are ...Noodls, 4 weeks ago Multiple data presentations at leading European epilepsy congress highlight UCB's commitment to advancing epilepsy research Noodls, 1 month ago UCB announces encouraging data from two partial-onset seizure studies Individual.com, 3 weeks ago
Total synthesis of anticonvulsant amino acid, lacosamide, is reported. The key step is stereospecific allyl cyanate-to-isocyanate rearrangement, which proceeds with chirality transfer. The enantiopure starting material for the rearrangement step was ...Journal of Organic Chemistry, 1 month ago
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases . GlaxoSmithKline LLC et al. v. Glenmark Generics Inc. USA 1:14-cv-00877; filed July 3, 2014 in the District Court of Delaware • ...JD Supra, 1 day ago Seizures - Pipeline Review, H1 2014 Franklin Credit Management Corporation, 4 weeks ago
Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends wrong signals. Seizures could differ from primary ...Wall Street Select, 1 week ago Asia Epilepsy Therapeutics Market to rise slightly from $1.1bn in 2012 to $1.5bn in 2019 TransWorldNews, 4 weeks ago
By Targeted News Service ALEXANDRIA, Va., July 17 -- Quest Diagnostics Investments, Wilmington, Delaware, has been assigned a patent (8,779,355) developed by four co-inventors for "methods for detecting lacosamide byFinancial Content, 1 week ago
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
/PRNewswire/ -- Reportbuyer.com has added a new market research report: Summary GBI Research, the leading business intelligence provider, has released its latest research, " ", which provides in-depth analysis of epilepsy market within the ...MoneyShow.com, 1 week ago Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns TVNewsCheck, 2 weeks ago
More from: BioSpace, Minyanville...and 21 other sources
Introduction Diabetic neuropathy (DN) is a major cause of disability and reduced quality of life. In the previous review we discussed the prevalence, classification, clinical features, pathophysiology and recent advances in the diagnosis of ...JPMA, 1 month ago
InVivo Therapeutics Corporation(NVIV) Announces As Third Clinical Trial Site For Neuro-Spinal Scaffold 6/26/2014 8:53:34 AM More... New Vision of How We Explore Our World, Barrow Neurological Institute Study 4/5/2013 11:45:31 AM More... ...ClinicSpace, 1 month ago
"Use of the Phytocannabinoid Cannabidiol (Cbd) in Combination with a Standard Anti-Epileptic Drug (Saed) in the Treatment of Epilepsy" in Patent...
"Use of the Phytocannabinoid Cannabidiol (Cbd) in Combination with a Standard Anti-Epileptic Drug (Saed) in the Treatment of Epilepsy" in Patent Application Approval Process By a News Reporter-Staff News Editor at Pharma Business Week -- A patent ...4 Traders, 1 month ago
on your WebpageAdd Widget >Get your members hooked!